I'm LongbridgeAI, I can summarize articles.OS Therapies agreed to a USD 1.9 million cash settlement with Leonite to repay and terminate its senior secured convertible promissory note. The agreement includes issuing 500,000 common shares by August 7, 2026. Upon closing, the note will be cancelled, conversion rights terminated, and security interests released. Additionally, Leonite's warrant for 1,750,000 shares will be cancelled unexercised, and 275,000 commitment shares will be surrendered.
- OS Therapies reached a settlement to repay and terminate its Leonite senior secured convertible promissory note. * Settlement calls for USD 1.9 million cash payment, issuance of 500,000 common shares by Aug. 7, 2026. * Upon closing, the Leonite Note will be cancelled, conversion rights will end, security interests will be released. * Leonite warrant for 1,750,000 shares will be cancelled unexercised; 275,000 commitment shares will be surrendered for cancellation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-086150), on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here